ArticleResearch in health services & regions2025
Educational differences in cancer incidence, stage at time of diagnosis, and survival in Norway.
Article in Research in health services & regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe study investigates differences in cancer incidence, stage, and survival between municipalities with varying levels of education in Norway. It replicates the design of a similar study conducted in Oslo to assess whether similar patterns are present nationwide.
methodWe used aggregated data from the Cancer Registry of Norway (2014-2023) to calculate age-standardized incidence rates, stage at diagnosis, and five-year relative survival for colon, rectal, lung, melanoma, breast, and prostate cancer across municipalities. Municipalities were grouped by educational level (low, medium, high), and outcomes were compared.
resultsThe study included 191,213 cases. Age-standardized incidence rates (per 100,000 person-years) differed significantly by education for all cancer types except breast cancer (p = 0.70). Melanoma and breast cancer incidence was highest in high-education areas (melanoma: 45.2 vs. 36.9; breast: 135.6 vs. 120.3), while lung cancer was highest in low-education areas (64.4 vs. 56.3). Colon, rectal, and prostate showed smaller but significant differences (colon: 54.7 vs. 54.5, p < 0.001; rectal: 24.5 vs. 25.9, p < 0.001; prostate: 189.8 vs. 191.5, p < 0.001). Low-education areas had the highest proportion of distant metastases for most cancers, with significant variation for lung (p = 0.003) and prostate (p < 0.001). Mid- or high-education areas more often had localized disease, except melanoma. Low-education areas had lower five-year relative survival, significant only for breast cancer (p = 0.037).
conclusionCancer incidence, stage, and survival varied between municipalities grouped by inhabitants' educational level. Findings align with those of the Oslo study, highlighting consistent education-related disparities in cancer outcomes nationwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.